Skip to main content

Table 2 Secondary maternal and neonatal outcomes

From: Effect of delayed misoprostol dosing interval for induction of labor: a retrospective study

Outcome

Routine Dosing

n = 64

Delayed Dosing

n = 69

P Value

Vaginal Delivery

55 (86%)

52 (75%)

P = .13

Operative Vaginal Delivery

0

6 (8.6%)

N/A

Cesarean Delivery

9 (14%)

12 (18.8%)

P = .81

Estimated Blood Loss

455 mL (+/− 348.14)

489 mL (+/−  357.6)

P = .58

Post-Partum Hemorrhage

10 (15.63%)

15 (21.7%)

P = .39

Meconium

6 (9.38%)

7 (10.1%)

P = 1.0

Chorioamnionitis

1 (1.56%)

0

N/A

Shoulder Dystocia

2 (3.13%)

0

N/A

1 min APGAR

7.6 (+/− 1.66)

7.5 (+/−1.95)

P = .75

5 min APGAR

8.7 (+/− .87)

8.6 (+/− 1.05)

P = .55

NICU stay

4 (6.25%)

10 (14.5%)

P = .16

  1. Maternal and neonatal outcomes at delivery by dosing interval. Patients in the delayed interval dosing group had at least one dosing interval longer than 4.5 h. Categorical variables are reported as n, (%), and were compared using chi squared or Fischer’s exact tests. Continuous variables are reported as mean (+/− standard deviation), and were compared using Student’s T-test